APO RESEARCH · REPORT
Glabridin
Glabridin is a chemical compound that is found in the root extract of licorice (Glycyrrhiza glabra). Glabridin is an isoflavane, a type of isoflavonoid. This product is part of a larger family of plant-derived molecules, the natural phenols. Glabridin is yellowish-brown powder. It is insoluble in water, but soluble in organic solvents such as propylene glycol.
Product & engineering
Understand the product.
Glabridin is a chemical compound that is found in the root extract of licorice (Glycyrrhiza glabra). Glabridin is an isoflavane, a type of isoflavonoid. This product is part of a larger family of plant-derived molecules, the natural phenols. Glabridin is yellowish-brown powder. It is insoluble in water, but soluble in organic solvents such as propylene glycol.
Selected research
Industry Growth & Trends
Global Glabridin Industry Growth and Trends Forecast to 2032
Market perspective
Glabridin is a chemical compound that is found in the root extract of licorice (Glycyrrhiza glabra). Glabridin is an isoflavane, a type of isoflavonoid. This product is part of a larger family of plant-derived molecules, the natural phenols. Glabridin is yellowish-brown powder. It is insoluble in water, but soluble in organic solvents such as propylene glycol.
Global Glabridin market can be divided into 20% (HPLC), 40% (HPLC), 60% (HPLC), 90% (HPLC), 98% (HPLC) and Others according to the content of active ingredients. Among them, 40% (HPLC) is the most widely used. Glabridin 40% (HPLC) was estimated to account for a revenue share of 43.54% in 2020. In 2020, Glabridin 40% (HPLC) segment is estimated to be valued at 7778 K USD which is expected to reach at 10718 K USD in 2026, with a CAGR of 5.49% over the forecast period.
Global Glabridin Application segment consists of Cosmetic and Pharmaceutical. Cosmetic was estimated to account for a sales share of 89.17% in 2020. In 2020, the Cosmetic segment is estimated to sale at 2086 Kg which is expected to reach at 2685 Kg in 2026, with a CAGR of 4.29% over the forecast period.This report focuses on the Glabridin in global market, especially in North America, Europe, China, India and Japan. As the largest producer, China produced 949 Kg of Glabridin in 2019, accounting for 37.85% of the global total. The United States is the most important consumer country, with consumption accounting for 24.28% of the global in 2019.
Read the full market overview
Report Scope
This report provides a structured, data-driven view of the global Glabridin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Glabridin market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Glabridin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Glabridin.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Glabridin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Glabridin Market by Company
Sabinsa
Alchem International
MAFCO
Plamed Green Science Group
Xi'an Zhongying
Spring Autumn Biological
Huaian Brothers Biotechnology
Xi’an Tianye Biotech
Maruzen Pharmaceuticals
SK Bioland
Sunpure Extracts
Glabridin Segment by Type
20% (HPLC)
40% (HPLC)
60% (HPLC)
90% (HPLC)
98% (HPLC)
Other
Glabridin Segment by Application
Cosmetic
Pharmaceutical
Glabridin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glabridin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glabridin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glabridin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Glabridin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Glabridin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 20% (HPLC)
- 40% (HPLC)
- 60% (HPLC)
- 90% (HPLC)
- 98% (HPLC)
- Other
Applications
- Cosmetic
- Pharmaceutical
Companies covered
- Sabinsa
- Alchem International
- MAFCO
- Plamed Green Science Group
- Xi'an Zhongying
- Spring Autumn Biological
- Huaian Brothers Biotechnology
- Xi’an Tianye Biotech
- Maruzen Pharmaceuticals
- SK Bioland
- Sunpure Extracts
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Glabridin Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Glabridin Sales Estimates and Forecasts (2021-2032)
- 1.3 Glabridin Market by Type
- 1.3.1 20% (HPLC)
- 1.3.2 40% (HPLC)
- 1.3.3 60% (HPLC)
- 1.3.4 90% (HPLC)
- 1.3.5 98% (HPLC)
- 1.3.6 Other
- 1.4 Global Glabridin Market Size by Type
- 1.4.1 Global Glabridin Market Size Overview by Type (2021-2032)
- 1.4.2 Global Glabridin Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Glabridin Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Glabridin Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Glabridin Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Glabridin Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Glabridin Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Glabridin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Glabridin Industry Trends
- 2.2 Glabridin Industry Drivers
- 2.3 Glabridin Industry Opportunities and Challenges
- 2.4 Glabridin Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Glabridin Revenue (2021-2026)
- 3.2 Global Top Players by Glabridin Sales (2021-2026)
- 3.3 Global Top Players by Glabridin Price (2021-2026)
- 3.4 Global Glabridin Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Glabridin Major Company Production Sites & Headquarters
- 3.6 Global Glabridin Company, Product Type & Application
- 3.7 Global Glabridin Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Glabridin Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Glabridin Players Market Share by Revenue in 2025
- 3.8.3 2025 Glabridin Tier 1, Tier 2, and Tier 3
4 Glabridin Regional Status and Outlook
- 4.1 Global Glabridin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Glabridin Historic Market Size by Region
- 4.2.1 Global Glabridin Sales in Volume by Region (2021-2026)
- 4.2.2 Global Glabridin Sales in Value by Region (2021-2026)
- 4.2.3 Global Glabridin Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Glabridin Forecasted Market Size by Region
- 4.3.1 Global Glabridin Sales in Volume by Region (2027-2032)
- 4.3.2 Global Glabridin Sales in Value by Region (2027-2032)
- 4.3.3 Global Glabridin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Glabridin by Application
- 5.1 Glabridin Market by Application
- 5.1.1 Cosmetic
- 5.1.2 Pharmaceutical
- 5.2 Global Glabridin Market Size by Application
- 5.2.1 Global Glabridin Market Size Overview by Application (2021-2032)
- 5.2.2 Global Glabridin Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Glabridin Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Glabridin Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Glabridin Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Glabridin Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Glabridin Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Glabridin Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Sabinsa
- 6.1.1 Sabinsa Company Information
- 6.1.2 Sabinsa Business Overview
- 6.1.3 Sabinsa Glabridin Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Sabinsa Glabridin Product Portfolio
- 6.1.5 Sabinsa Recent Developments
- 6.2 Alchem International
- 6.2.1 Alchem International Company Information
- 6.2.2 Alchem International Business Overview
- 6.2.3 Alchem International Glabridin Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Alchem International Glabridin Product Portfolio
- 6.2.5 Alchem International Recent Developments
- 6.3 MAFCO
- 6.3.1 MAFCO Company Information
- 6.3.2 MAFCO Business Overview
- 6.3.3 MAFCO Glabridin Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 MAFCO Glabridin Product Portfolio
- 6.3.5 MAFCO Recent Developments
- 6.4 Plamed Green Science Group
- 6.4.1 Plamed Green Science Group Company Information
- 6.4.2 Plamed Green Science Group Business Overview
- 6.4.3 Plamed Green Science Group Glabridin Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Plamed Green Science Group Glabridin Product Portfolio
- 6.4.5 Plamed Green Science Group Recent Developments
- 6.5 Xi'an Zhongying
- 6.5.1 Xi'an Zhongying Company Information
- 6.5.2 Xi'an Zhongying Business Overview
- 6.5.3 Xi'an Zhongying Glabridin Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Xi'an Zhongying Glabridin Product Portfolio
- 6.5.5 Xi'an Zhongying Recent Developments
- 6.6 Spring Autumn Biological
- 6.6.1 Spring Autumn Biological Company Information
- 6.6.2 Spring Autumn Biological Business Overview
- 6.6.3 Spring Autumn Biological Glabridin Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Spring Autumn Biological Glabridin Product Portfolio
- 6.6.5 Spring Autumn Biological Recent Developments
- 6.7 Huaian Brothers Biotechnology
- 6.7.1 Huaian Brothers Biotechnology Company Information
- 6.7.2 Huaian Brothers Biotechnology Business Overview
- 6.7.3 Huaian Brothers Biotechnology Glabridin Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Huaian Brothers Biotechnology Glabridin Product Portfolio
- 6.7.5 Huaian Brothers Biotechnology Recent Developments
- 6.8 Xi’an Tianye Biotech
- 6.8.1 Xi’an Tianye Biotech Company Information
- 6.8.2 Xi’an Tianye Biotech Business Overview
- 6.8.3 Xi’an Tianye Biotech Glabridin Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Xi’an Tianye Biotech Glabridin Product Portfolio
- 6.8.5 Xi’an Tianye Biotech Recent Developments
- 6.9 Maruzen Pharmaceuticals
- 6.9.1 Maruzen Pharmaceuticals Company Information
- 6.9.2 Maruzen Pharmaceuticals Business Overview
- 6.9.3 Maruzen Pharmaceuticals Glabridin Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Maruzen Pharmaceuticals Glabridin Product Portfolio
- 6.9.5 Maruzen Pharmaceuticals Recent Developments
- 6.10 SK Bioland
- 6.10.1 SK Bioland Company Information
- 6.10.2 SK Bioland Business Overview
- 6.10.3 SK Bioland Glabridin Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 SK Bioland Glabridin Product Portfolio
- 6.10.5 SK Bioland Recent Developments
- 6.11 Sunpure Extracts
- 6.11.1 Sunpure Extracts Company Information
- 6.11.2 Sunpure Extracts Business Overview
- 6.11.3 Sunpure Extracts Glabridin Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Sunpure Extracts Glabridin Product Portfolio
- 6.11.5 Sunpure Extracts Recent Developments
7 North America by Country
- 7.1 North America Glabridin Sales by Country
- 7.1.1 North America Glabridin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Glabridin Sales by Country (2021-2026)
- 7.1.3 North America Glabridin Sales Forecast by Country (2027-2032)
- 7.2 North America Glabridin Market Size by Country
- 7.2.1 North America Glabridin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Glabridin Market Size by Country (2021-2026)
- 7.2.3 North America Glabridin Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Glabridin Sales by Country
- 8.1.1 Europe Glabridin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Glabridin Sales by Country (2021-2026)
- 8.1.3 Europe Glabridin Sales Forecast by Country (2027-2032)
- 8.2 Europe Glabridin Market Size by Country
- 8.2.1 Europe Glabridin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Glabridin Market Size by Country (2021-2026)
- 8.2.3 Europe Glabridin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Glabridin Sales by Country
- 9.1.1 Asia-Pacific Glabridin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Glabridin Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Glabridin Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Glabridin Market Size by Country
- 9.2.1 Asia-Pacific Glabridin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Glabridin Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Glabridin Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Glabridin Sales by Country
- 10.1.1 South America Glabridin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Glabridin Sales by Country (2021-2026)
- 10.1.3 South America Glabridin Sales Forecast by Country (2027-2032)
- 10.2 South America Glabridin Market Size by Country
- 10.2.1 South America Glabridin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Glabridin Market Size by Country (2021-2026)
- 10.2.3 South America Glabridin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Glabridin Sales by Country
- 11.1.1 Middle East and Africa Glabridin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Glabridin Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Glabridin Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Glabridin Market Size by Country
- 11.2.1 Middle East and Africa Glabridin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Glabridin Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Glabridin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Glabridin Value Chain Analysis
- 12.1.1 Glabridin Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Glabridin Production Mode & Process
- 12.2 Glabridin Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Glabridin Distributors
- 12.2.3 Glabridin Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst